Live Cancer Institute and Zhongshan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Mol Biotechnol. 2012 Jan;50(1):49-56. doi: 10.1007/s12033-011-9414-6.
Circulating microRNAs (miRNAs) were found to exist in serum/plasma in a highly stable, cell-free form, and aberrantly expressed in many human diseases. Currently, the expression levels of circulating miRNAs are estimated by quantitative real-time polymerase chain reaction. However, no study has systematically evaluated reference genes for evaluating circulating microRNA expression. This study describes the identification and characterization of an appropriate reference gene for the normalization of circulating miRNA levels in hepatitis B virus (HBV)-infected patients and healthy people. Ten miRNAs that resemble the mean expression of the TaqMan low density array together with U6, RNU6B, and miR-16 were validated with two algorithms, geNorm, and NormFinder, after ensuring their equivalent expression between the two study groups. The combination of miR-26a, miR-221, and miR-22* is recommended as the most stable set of reference genes for circulating miRNA evaluation in HBV patients and healthy people.
循环 microRNAs(miRNAs)被发现以高度稳定的无细胞形式存在于血清/血浆中,并且在许多人类疾病中表达异常。目前,循环 miRNAs 的表达水平通过定量实时聚合酶链反应来估计。然而,尚无研究系统地评估用于评估循环 miRNA 表达的参考基因。本研究描述了鉴定和表征乙型肝炎病毒(HBV)感染患者和健康人群中循环 miRNA 水平标准化的合适参考基因。在确保两组间表达相等后,使用 geNorm 和 NormFinder 两种算法对与 TaqMan 低密度阵列平均表达相似的 10 个 miRNA 以及 U6、RNU6B 和 miR-16 进行了验证。推荐 miR-26a、miR-221 和 miR-22*的组合作为 HBV 患者和健康人群中循环 miRNA 评价最稳定的参考基因集。